Molecular Mechanisms of Endocrine Resistance in Estrogen-Positive Breast Cancer

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Estrogen receptor (ER)-positive breast cancer is a major health concern.
• Endocrine therapy is a primary treatment, but endocrine resistance limits its efficacy.
• Resistance can be de novo or acquired, necessitating a deeper understanding of underlying mechanisms.

Purpose of the Study:

• To review the mechanisms driving endocrine resistance in ER-positive breast cancer.
• To explore both ligand-dependent and ligand-independent pathways involved in resistance.
• To identify potential therapeutic strategies to overcome endocrine resistance.

Main Methods:

• Literature review of studies on estrogen receptor signaling and endocrine resistance.
• Analysis of molecular mechanisms, including ligand-dependent and independent pathways.
• Examination of the role of coregulators in resistance development.

Main Results:

• Endocrine resistance involves complex ligand-dependent and ligand-independent signaling.
• Various coregulatory proteins play critical roles in mediating resistance.
• Understanding these pathways is key to developing effective treatment strategies.

Conclusions:

• Combinatorial drug approaches targeting multiple signaling pathways are promising.
• Simultaneous targeting of coregulatory proteins alongside endocrine therapy may overcome resistance.
• Novel therapeutic modalities are needed to improve outcomes for patients with resistant breast cancer.